Neutralization of colony-stimulating factor 1 receptor prevents sickness behavior syndrome by reprogramming inflammatory monocytes to produce IL-10

Brain, Behavior, and Immunity
Andreas Felix MüllerAdriano Fontana

Abstract

Sickness behavior syndrome (SBS) as characterized by fatigue and depression impairs quality of life in patients with inflammatory diseases caused by infections and autoimmunity. Systemic engagement of CD40 in mice leads to an inflammatory syndrome with acute hepatitis, lymphadenopathy and development of SBS as evidenced by induction of sleep and weight loss. In the study presented here we show that the elimination of resident tissue macrophages in mice by antibody-mediated neutralization of colony-stimulating factor-1 receptor (CSF1R) did not prevent CD40 induced hepatitis, but conferred resistance to the development of SBS. The protective effect of CSF1R mAb on weight loss and behavior changes induced by CD40 activation coincided with the transformation of pro-inflammatory monocytes to IL-10 producing myeloid cells. In IL-10 knockout mice CSF1R neutralization failed to exert protection from the occurrence of SBS. This study establishes the unexpected key role of CSF1R in the polarization of inflammatory monocytes and thereby SBS in inflammatory liver diseases.

References

Apr 9, 2004·Proceedings of the National Academy of Sciences of the United States of America·Frank A W VerreckTom H M Ottenhoff
Jul 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Feng ZhouMark G Swain
Feb 2, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Marlyn J MayoPeter E Lipsky
Mar 2, 2006·The American Journal of Pathology·Kiminori KimuraFrancis V Chisari
Dec 13, 2007·Nature Reviews. Neuroscience·Robert DantzerKeith W Kelley
Dec 25, 2008·Annual Review of Immunology·Fernando O MartinezSiamon Gordon
May 12, 2009·Immunological Reviews·Raul ElguetaRandolph J Noelle
Dec 17, 2009·The Journal of Experimental Medicine·Florent GinhouxMiriam Merad
Nov 16, 2010·Brain, Behavior, and Immunity·Cornelia TaraborrelliAdriano Fontana
Nov 26, 2010·Journal of Leukocyte Biology·Kiminori KimuraMichinori Kohara
Aug 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Evaggelia LiaskouDavid H Adams
Oct 18, 2012·Brain, Behavior, and Immunity·Heidemarie GastAdriano Fontana
Jun 27, 2013·World Journal of Gastroenterology : WJG·Mohammad Reza AbdollahiEsmaeil Faraji
Sep 24, 2013·Nature Medicine·Stephanie M PyonteckJohanna A Joyce

❮ Previous
Next ❯

Citations

Oct 7, 2015·Brain, Behavior, and Immunity·Justin L BollingerCara L Wellman
Dec 30, 2017·Journal of Translational Medicine·Megan E RoerinkJos W M van der Meer
Jun 2, 2020·Journal of Neuroinflammation·Elisabeth G VichayaRobert Dantzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.